Mycovia Pharmaceuticals Inc.

This study tested whether a medication called oteseconazole could prevent recurrent yeast infections in women who experience them frequently. 438 women who had at least 3 yeast infections in the past year took either the study pill or a placebo (dummy pill) for 12 weeks, then wer…

This study tested whether a new oral medication called oteseconazole could safely prevent recurrent yeast infections in women. Over 400 women who typically had at least three infections a year were randomly assigned to take either the new drug or a placebo pill for 12 weeks, then…